Regulation by C5a of neutrophil activation during sepsis. (Q47672797)

4 February 2018

title

Regulation by C5a of neutrophil activation during sepsis. (English)

1 reference

4 February 2018

1 reference

11

Peter A Ward

1 reference

4 February 2018

10

Firas S Zetoune

1 reference

4 February 2018

9

Vidya J Sarma

1 reference

4 February 2018

Cecilia L Speyer

8

Cecilia Speyer

1 reference

4 February 2018

Kurt D Bernacki

3

Kurt D Bernacki

1 reference

4 February 2018

Niels Riedemann

1

Niels C Riedemann

1 reference

4 February 2018

Ines J. Laudes

5

Ines J Laudes

1 reference

4 February 2018

Jayne S Reuben

4

Jayne S Reuben

1 reference

4 February 2018

author name string

Ren-Feng Guo

2

1 reference

4 February 2018

Thomas A Neff

6

1 reference

4 February 2018

Hongwei Gao

7

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 August 2003

1 reference

4 February 2018

published in

Immunity

1 reference

4 February 2018

volume

19

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

page(s)

193-202

1 reference

4 February 2018

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Protective effects of C5a blockade in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Role of C5a in multiorgan failure during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Protective effects of anti-C5a peptide antibodies in experimental sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Complement-induced impairment of innate immunity during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

NF-kappaB regulation in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Activation of distinct transcription factors in neutrophils by bacterial LPS, interferon-gamma, and GM-CSF and the necessity to overcome the action of endogenous proteases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Anaphylatoxins C5a and C3a induce nuclear factor kappaB activation in human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

C5a receptor and thymocyte apoptosis in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Increased C5a receptor expression in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Expression and function of the C5a receptor in rat alveolar epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2803%2900206-1

7 January 2021

10.1016/S1074-7613(03)00206-1

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

12932353

1 reference

4 February 2018